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Sarcoidosis is a systemic granulomatous inﬂammation of unknown etiology,  and seems to involve the 
liver parenchyma in most cases.  However,  sarcoidosis-associated hepatocellular carcinoma is rare.  
We report here a case in which a hepatocellular carcinoma occurred within the liver,  which was prob-
ably involved as a result of systemic sarcoidosis.  A 57-year-old Japanese man had been followed up 
for 2 years because of diabetic nephropathy and sarcoidosis.  On admission for pneumonia,  imaging 
studies revealed an unexpected hepatic tumor.  Histology revealed a hepatocellular carcinoma accom-
panied by T-lymphocytic inﬁltration and marked granulomatous inﬂammation,  which was surround-
ing some tumor nodules.  The background liver parenchyma exhibited a moderate degree of ﬁbrosis 
with granulomatous inﬂammation.  The patient had no other apparent liver disease such as viral hepa-
titis,  steatohepatitis,  or primary biliary cirrhosis.  Therefore,  in the present case,  sarcoidosis may be 
considered the probable background etiology for hepatocarcinogenesis.
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arcoidosis is a multisystem disease with granu-
lomatous inﬂammation,  and after lung and 
lymph nodes the liver is considered one of the organs 
likely to be most involved by sarcoidosis [1,  2].  
However,  cases of sarcoidosis-associated hepatocel-
lular carcinoma (HCC) are believed to be rare.  Here,  
we present such a case in a Japanese man and discuss 
sarcoid liver disease and hepatocarcinogenesis.
Case Report
　 A 57-year-old,  diabetic Japanese man was admit-
ted to the National Defense Medical College Hospital 
(Tokorozawa,  Japan) because of nephrotic syndrome.  
He had routinely drunk approximately 60g of alcohol 
daily for 30 years,  but had abstained for the last 2 
years.  Upon examination for nephrotic syndrome,  he 
had been found to have swelling of the bilateral lung 
hilar and abdominal paraaortic lymph nodes,  accompa-
nied by elevations in the serum value for interleukin-2 
receptor and in the uptake of radioisotopes in gallium 
scintigraphy.  To rule out malignancies,  biopsy of an 
abdominal paraaortic lymph node had been performed,  
and histology had identiﬁed a granulomatous lymph-
adenitis without necrosis or acid-fast bacilli.  An 
accompanying renal biopsy had revealed the existence 
of diabetic nephropathy. A negative tuberculin skin 
(Mantoux) test and elevations in both the value for 
angiotensin-converting enzyme and the CD4/8 ratio in 
bronchoalveolar ﬂuid had supported the diagnosis of 
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sarcoidosis.  No uveitis was evident on slit-lamp 
examination.  
　 The patient was followed up in the outpatient oﬃce 
for a 2-year symptom-stable period,  but he then 
complained of respiratory distress after ﬂu-like symp-
toms.  Imaging studies on admission revealed bilateral 
pulmonary inﬁltrates with a ground-glass appearance.  
Uremic lung or pneumonia and adult respiratory dis-
tress syndrome were considered,  and both his symp-
toms and the radiologic inﬁltrates were resolved by 
treatment with antibiotics and corticosteroids.  
However,  on the follow-up chest computed tomogram 
(CT),  an unexpected hepatic tumor was found (Fig.  
1).  Laboratory data revealed him to be low in hemo-
globin,  platelet number,  and serum albumin,  and also 
revealed high serum values for blood urea nitrogen,  
creatinine,  and protein induced by vitamin K absence 
or antagonist-II (PIVKA-II).  Serum hepatitis B sur-
face antigen and hepatitis C virus antibody were nega-
tive,  and transaminases,  angiotensin-converting enzyme,  
and alpha feto-protein values were each within the 
normal range.  The retention of indocyanine green at 
15 min after its injection was 7.5ｵ.  The liver tumor 
was suspected to be a HCC,  although a sarcoid nodule 
could not be ruled out because he had sarcoidosis.
　 HCC was diagnosed by pathology using a specimen 
obtained in a needle-biopsy examination,  and a subse-
quent partial liver resection was performed.  A simple 
nodular-type tumor,  sized 32×25×24mm,  was found 
within the resected specimen.  Histology revealed a 
thin-trabecular and pseudo-glandular proliferation of 
tumor cells (Fig.  2A).  These tumor cells possessed 
rounded nuclei with distinct nucleoli and an eosino-
philic polygonal cytoplasm,  and some displayed fatty 
degeneration (Fig.  2B).  The tumor was diagnosed as 
a grade 2 HCC.  Interestingly,  the tumor was associ-
ated with marked granulomatous inﬂammation and 
lymphocytic inﬁltration.  These non-caseating granulo-
mas were found circumferentially in the tumor capsule 
and septa (Fig.  2C,  E),  and were highlighted by the 
histiocytic marker CD68 (clone KP-1; Dako,  
Glostrup,  Denmark; Fig.  2D,  F).  The accompanying 
lymphocytes were predominantly immunoreactive for 
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Fig. 1　 A low-density mass (arrowheads) was incidentally found 
in the right lobe of the liver on the plain chest computed tomogram.  
Scale divisions represent 1cm each.
Fig.  2　 A,  Cut surface of the hepatic mass exhibited a whitish expanding tumor with a ﬁbrous capsule.  A nodule-in-nodule appearance 
was vaguely recognized.  Scale divisions represent 5mm each; B,  Histologically,  the tumor cells displayed fatty degeneration and were 
accompanied by non-caseating granulomas (arrowheads) and small lymphocytes (hematoxylin-eosin; scale bar indicates 50μm); C-F,  
Tumor-cell nests were surrounded by granulomatous inﬂammation (arrowheads),  which was highlighted by the histiocytic marker KP-1 (C,  
E: hematoxylin-eosin; D,  F: diaminobenzidine; scale bars indicate 500μm in C,  D,  and 100μm in E,  F).
the T-cell marker CD45RO (clone UCHL-1; Dako).  
No vessel permeation or intrahepatic metastases by 
tumor cells was observed.  The background hepatic 
parenchyma contained non-caseating granulomas to a 
lesser degree than the tumor itself,  and ﬁbrosis was 
predominantly seen connecting among portal areas.  No 
apparent features of steatohepatitis,  primary biliary 
cirrhosis,  or any other liver disease were observed.  
These ﬁndings are compatible with liver involvement 
by sarcoidosis.  The post-operative period was 
uneventful,  and the patient has been followed up for 2 
years since the operation,  without any recurrence of 
the liver tumor.
Discussion
　 Sarcoidosis is a systemic granulomatous inﬂ amma-
tion with an unknown etiology.  In some studies of 
patients with sarcoidosis,  hepatic granulomas have 
been found in as many as 70ｵ of autopsy cases [3] 
and in 50-65ｵ of liver biopsy cases [1].  Conversely,  
in a recent large-scale study,  only 3.6ｵ of liver 
biopsy samples included granulomas,  with almost half 
of the samples with granulomas being diagnosed as 
primary biliary cirrhosis and approximately 8ｵ as 
sarcoidosis [4].  Most patients with hepatic sarcoido-
sis are asymptomatic and have normal liver enzyme 
tests.  Abnormalities in liver function tests are recog-
nized in 20-40ｵ of sarcoid patients [1],  and liver 
enlargement can be found on ultrasound or CT in up 
to 50ｵ of cases.  On CT,  the liver appears homoge-
nous in the cases with organomegaly.  In 5-15ｵ of 
cases,  sarcoid liver disease manifests itself as multi-
ple,  small (＜1cm) nodules [1,  5,  6].  However,  as 
they increase in size,  malignancy or other infectious 
causes should be included in the diﬀerential diagnosis.  
The precise frequency with which sarcoid liver is 
detected on magnetic resonance imaging remains 
unclear,  despite the publication of reports describing 
the ﬁndings of such imaging [7,  8].  Rarely,  sarcoid 
liver disease can cause cirrhosis and portal hyperten-
sion [9].  
　 Among patients with sarcoidosis,  an increasing risk 
of cancer is indicated by reports from Japan [10] and 
from Sweden [11].  In the former,  death by lung 
cancer associated with sarcoidosis was high,  while in 
the latter,  lung cancer,  non-Hodgkinʼs lymphoma,  skin 
cancers,  and furthermore liver cancer occurred even 
more frequently.  Therefore,  the Swedish authors 
proposed chronic inﬂammation as a putative mediator 
of carcinogenic risk [11].  In general,  chronic inﬂam-
mation is associated with an increased risk of cancers 
in the aﬀected tissues [12].  Speciﬁcally,  repeated 
tissue damage and regeneration of tissue,  in the pres-
ence of the highly reactive nitrogen and oxygen species 
released from inﬂammatory cells,  interacts with DNA 
in the proliferating epithelium,  resulting in permanent 
genomic alterations such as point mutations,  deletions,  
or rearrangements.  On the basis of the above ﬁndings,  
hepatocellular damage and regeneration caused by 
inﬂammation may be considered to be an essential step 
in the carcinogenesis of sarcoidosis-associated HCC,  
as in the carcinogenesis associated with viral hepatitis 
[13].  Actually,  cases of HCC in sarcoidosis are 
extremely rare [11,  14,  15],  and one of these 
reported cases was complicated by cirrhosis [15].  
Such a rare association of sarcoidosis with HCC may 
reﬂect the presence of relatively weak inﬂammation or 
weak hepatocytic regeneration in sarcoid liver disease.  
However,  even if this is a rare association,  clinicians 
should include primary liver cancer in the list used for 
the diﬀerential diagnosis of a liver mass in sarcoidosis 
patients.  For diﬀerential diagnosis,  both the increase 
in the serum values of tumor-marker proteins and the 
needle-biopsy procedure were useful.  
　 In the present case,  granulomatous inﬂammation 
with associated T-cell inﬁltration was observed in the 
liver,  and this inﬂammation was present more strongly 
in the tumor itself than in the background liver paren-
chyma.  This granulomatous reaction in the tumor may 
be similar to the so-called sarcoid-like reaction,  which 
is frequently observed in the lymph nodes draining a 
metastatic tumor,  and is considered to be an immuno-
reaction to the tumor [16].  A preponderance of 
granulomatous inﬂammation within the tumor,  as 
observed in the present case,  may be one of the char-
acteristic features of sarcoidosis-associated cancers.  
Despite a favorable-looking suggesting host immunity 
against the tumor,  its signiﬁcance on prognosis is 
unclear because the so-called sarcoid-like reaction 
itself may not be signiﬁcant as a positive inﬂuence on 
cancer-patient prognosis [16].
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